Prelude Capital Management’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,429
| Closed | -$109K | – | 974 |
|
|
2023
Q3 | $109K | Sell |
25,429
-1,563
| -6% | -$6.72K | 0.01% | 841 |
|
|
2023
Q2 | $140K | Buy |
26,992
+11,772
| +77% | +$61.1K | 0.01% | 778 |
|
|
2023
Q1 | $103K | Buy |
15,220
+3,375
| +28% | +$23K | 0.01% | 853 |
|
|
2022
Q4 | $29K | Sell |
11,845
-1,316
| -10% | -$3.22K | ﹤0.01% | 1015 |
|
|
2022
Q3 | $43K | Buy |
13,161
+3,053
| +30% | +$9.98K | ﹤0.01% | 1194 |
|
|
2022
Q2 | $49K | Buy |
+10,108
| New | +$49K | ﹤0.01% | 1262 |
|
|
2017
Q3 | – | Sell |
-3
| Closed | -$2K | – | 1451 |
|
|
2017
Q2 | $2K | Sell |
3
-7
| -70% | -$4.67K | ﹤0.01% | 1395 |
|
|
2017
Q1 | $9K | Buy |
10
+6
| +150% | +$5.4K | ﹤0.01% | 1297 |
|
|
2016
Q4 | $4K | Buy |
4
+1
| +33% | +$1K | ﹤0.01% | 1402 |
|
|
2016
Q3 | $3K | Buy |
3
+1
| +50% | +$1K | ﹤0.01% | 1439 |
|
|
2016
Q2 | $5K | Buy |
+2
| New | +$5K | ﹤0.01% | 1396 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$11K | – | 1822 |
|
|
2014
Q4 | $11K | Hold |
2
| – | – | ﹤0.01% | 1694 |
|
|
2014
Q3 | $12K | Hold |
2
| – | – | ﹤0.01% | 1662 |
|
|
2014
Q2 | $17K | Hold |
2
| – | – | ﹤0.01% | 1586 |
|
|
2014
Q1 | $39K | Buy |
2
+1
| +100% | +$19.5K | 0.01% | 1221 |
|
|
2013
Q4 | $17K | Hold |
1
| – | – | ﹤0.01% | 1259 |
|
|
2013
Q3 | $18K | Sell |
1
-1
| -50% | -$18K | ﹤0.01% | 1104 |
|
|
2013
Q2 | $49K | Buy |
+2
| New | +$49K | 0.01% | 737 |
|